Iomeron (Iomeprol)

Iomeprol contains a high concentration of iodine atoms that absorb X‑ray photons. When injected, it increases the attenuation of the X‑ray beam in the area where it circulates, creating a clear contrast between enhanced structures and surrounding tissues for detailed radiographic imaging.

The dose of Iomeron is individualized by the prescribing radiologist or physician based on the specific imaging study, patient size, renal function and the required level of contrast enhancement. Exact dosing is determined at the point of care.

Iomeron is classified as Pregnancy Category B, indicating that animal studies have not shown risk to the fetus and there are no adequate human studies. It should only be used if clearly needed, and breastfeeding mothers should discuss potential risks with their healthcare provider.

To order Iomeron, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and necessary import documentation.

Iomeron (Iomeprol) offers a high iodine concentration with a low osmolality profile, which can reduce the incidence of discomfort and adverse reactions compared with older high‑osmolality agents. Its safety and imaging performance are comparable to other modern low‑osmolality iodinated contrast media.

Iomeron should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from moisture, direct sunlight and extreme temperatures. Do not freeze or shake the vial before use.

Iomeron is supplied as a sterile solution for injection and is administered intravenously, intra‑arterially, intra‑articularly or intrathecally by a qualified healthcare professional, following the imaging protocol for the specific diagnostic procedure.

Serious risks include severe allergic reactions such as anaphylaxis, acute kidney injury especially in patients with pre‑existing renal impairment, hypotension, cardiac arrhythmias, seizures and pulmonary edema. Immediate medical attention is required if any of these events occur.

Iomeron should be avoided in patients with known hypersensitivity to iodinated contrast media, uncontrolled severe renal insufficiency, active thyroid disease requiring iodine restriction, or in those who have had a recent severe reaction to another contrast agent. Clinical judgment is essential.